Drug Repurposing for Tooth Regeneration: The Promising Premises

Overview

Journal J Pharm Bioallied Sci

Specialty Pharmacology

Date 2022 Jan 12

PMID 35017906

Authors

T C Divya

Sapna Chandira Muddappa

Prabath Singh

Rakesh R Rajan

M Remya

Deepthy Sreehari

Affiliations

Soon will be listed here.

Abstract

Drug repurposing which identifies new therapeutic use(s) for drugs currently in use is a brand-new avenue of research interest worldwide. It circumvents the high-end monetary and time investment usually associated with contemporary drug discoveries. In the field of dentistry, recent studies in drug repurposing focuses in attaining dentin repair or reduction of bone resorption associated with apical periodontitis. Metformin, an anti-diabetic drug has shown pro-osteogenic properties. Aspirin a known anti-inflammatory agent with anticoagulant action is found to modulate the differentiation of dental pulp cells. The significant role of glycogen synthase kinase-3 inhibitors in activating the Wnt/-beta cat signaling pathway of mesenchymal pulp stem cells may pave the way to the pharmacological treatment of dental caries in near future. It is to be noted here that further preclinical and clinical studies are warranted for the regular therapeutic use of these potential drugs in clinical dentistry.

Citing Articles

Management of Patients Receiving Anticoagulation Therapy in Dental Practice: A Systematic Review.

Inchingolo F, Inchingolo A, Piras F, Ferrante L, Mancini A, Palermo A Healthcare (Basel). 2024; 12(15).

PMID: 39120240 PMC: 11311453. DOI: 10.3390/healthcare12151537.

Periodontal ligament stem cell-based bioactive constructs for bone tissue engineering.

Zhao Z, Liu J, Weir M, Schneider A, Ma T, Oates T Front Bioeng Biotechnol. 2022; 10:1071472.

PMID: 36532583 PMC: 9755356. DOI: 10.3389/fbioe.2022.1071472.

References

Ashburn T, Thor K . Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004; 3(8):673-83. DOI: 10.1038/nrd1468. View

Fuster V, Sweeny J . Aspirin: a historical and contemporary therapeutic overview. Circulation. 2011; 123(7):768-78. DOI: 10.1161/CIRCULATIONAHA.110.963843. View

Hooper C, Killick R, Lovestone S . The GSK3 hypothesis of Alzheimer's disease. J Neurochem. 2007; 104(6):1433-9. PMC: 3073119. DOI: 10.1111/j.1471-4159.2007.05194.x. View

Nicolini A, Grisa T, Muniz F, Rosing C, Cavagni J . Effect of adjuvant use of metformin on periodontal treatment: a systematic review and meta-analysis. Clin Oral Investig. 2018; 23(6):2659-2666. DOI: 10.1007/s00784-018-2666-9. View

Eldar-Finkelman H . Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol Med. 2002; 8(3):126-32. DOI: 10.1016/s1471-4914(01)02266-3. View

Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou A . Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med. 2004; 10(1):55-63. DOI: 10.1038/nm979. View

Lin S, Kok S, Lee Y, Hou K, Lin Y, Chen M . Simvastatin as a novel strategy to alleviate periapical lesions. J Endod. 2009; 35(5):657-62. DOI: 10.1016/j.joen.2009.02.004. View

Abd Rahman F, Mohd Ali J, Abdullah M, Abu Kasim N, Musa S . Aspirin Enhances Osteogenic Potential of Periodontal Ligament Stem Cells (PDLSCs) and Modulates the Expression Profile of Growth Factor-Associated Genes in PDLSCs. J Periodontol. 2016; 87(7):837-47. DOI: 10.1902/jop.2016.150610. View

Phung S, Lee C, Hong C, Song M, Yi J, Stevenson R . Effects of Bioactive Compounds on Odontogenic Differentiation and Mineralization. J Dent Res. 2016; 96(1):107-115. DOI: 10.1177/0022034516675152. View

10.

Lin S, Kok S, Yen-Ping Kuo M, Lee M, Wang C, Lan W . Nitric oxide promotes infectious bone resorption by enhancing cytokine-stimulated interstitial collagenase synthesis in osteoblasts. J Bone Miner Res. 2003; 18(1):39-46. DOI: 10.1359/jbmr.2003.18.1.39. View

11.

Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B . Metformin: from mechanisms of action to therapies. Cell Metab. 2014; 20(6):953-66. DOI: 10.1016/j.cmet.2014.09.018. View

12.

Rechenberg D, Galicia J, Peters O . Biological Markers for Pulpal Inflammation: A Systematic Review. PLoS One. 2016; 11(11):e0167289. PMC: 5127562. DOI: 10.1371/journal.pone.0167289. View

13.

Cai S, Liu A, Chen S, He H, Chen Q, Xu J . Activation of Wnt/β-catenin signalling promotes mesenchymal stem cells to repair injured alveolar epithelium induced by lipopolysaccharide in mice. Stem Cell Res Ther. 2015; 6:65. PMC: 4414385. DOI: 10.1186/s13287-015-0060-y. View

14.

Yuan M, Zhan Y, Hu W, Li Y, Xie X, Miao N . Aspirin promotes osteogenic differentiation of human dental pulp stem cells. Int J Mol Med. 2018; 42(4):1967-1976. PMC: 6108875. DOI: 10.3892/ijmm.2018.3801. View

15.

Nathan C . Inducible nitric oxide synthase: what difference does it make?. J Clin Invest. 1997; 100(10):2417-23. PMC: 508440. DOI: 10.1172/JCI119782. View

16.

Beurel E, Grieco S, Jope R . Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther. 2014; 148:114-31. PMC: 4340754. DOI: 10.1016/j.pharmthera.2014.11.016. View

17.

Labuzek K, Liber S, Gabryel B, Okopien B . Metformin has adenosine-monophosphate activated protein kinase (AMPK)-independent effects on LPS-stimulated rat primary microglial cultures. Pharmacol Rep. 2010; 62(5):827-48. DOI: 10.1016/s1734-1140(10)70343-1. View

18.

Sloan A, Smith A . Stem cells and the dental pulp: potential roles in dentine regeneration and repair. Oral Dis. 2007; 13(2):151-7. DOI: 10.1111/j.1601-0825.2006.01346.x. View

19.

Hong C, Lin S, Kok S, Cheng S, Lee M, Wang T . The role of lipopolysaccharide in infectious bone resorption of periapical lesion. J Oral Pathol Med. 2004; 33(3):162-9. DOI: 10.1111/j.0904-2512.2004.00045.x. View

20.

Neves V, Babb R, Chandrasekaran D, Sharpe P . Promotion of natural tooth repair by small molecule GSK3 antagonists. Sci Rep. 2017; 7:39654. PMC: 5220443. DOI: 10.1038/srep39654. View